Vaccine efficacy or effectiveness of 19F-containing vaccines against 19A disease. Depicted are point estimates with 95% confidence intervals from individual studies or metanalyses with at least five 19A cases. PS14-V, 14 valent polysaccharide vaccine; 7vCRM, 7-valent conjugate vaccine with crm197 carrier; 9vCRM, 9-valent conjugate vaccine candidate with crm197 carrier; 7vOMP, 7-valent conjugate vaccine candidate with outer membrane protein carrier; IPD, invasive pneumococcal disease; AOM, acute otitis media. See Table 1 for more study details.
Hausdorff et al. BMC Pediatrics 2010 10:4 doi:10.1186/1471-2431-10-4